The Children's Mercy oncology program is a national leader in cancer treatment. Our program provides pediatric patients with comprehensive clinical services and innovative treatment (including Phase I Experimental Therapeutics, stem cell transplantation, and immunotherapies such as CAR T-cell) supported by the latest research. We provide advanced treatment for children with cancer including brain tumors, leukemia, lymphoma, solid tumors (including Neuroblastoma, Wilms, Liver, Germ Cell, etc.). Bone and soft tissue tumors, histiocytic diseases, and vascular tumors.
Pediatric Oncologists Specialists
We are committed to ongoing research to help develop new, more effective treatments for childhood cancer. Because of that commitment, our survival rates are frequently above national averages. Our care team includes more than 25 pediatric oncologists and hematology specialists. Dedicated nurse practitioners help coordinate each step of treatment. This includes chemotherapy, surgery, radiation, labs, and any other services patients and families need from the time of diagnosis until care is completed. Our team creates a care plan suited to each patient's individual treatment needs.
Patients with Childhood Cancer Need the Best Care
We are active in national clinical trial groups, including the NCI's Children’s Oncology Group, the Pediatric Blood and Marrow Transplant Consortium and the Neuroblastoma and Medulloblastoma Translational Research Consortium. We are one of three consortium partners with the University of Kansas Cancer Center and Stowers Institute for Medical Research that make up the region's only NCI (National Cancer Institute) designated cancer center. In 2015, we once again received the highest accreditation for meeting patient-care standards from American College of Surgeons Commission on Cancer.
Cancer Treatment Outcomes in Children
Our team is driven to continually improve treatment outcomes for pediatric cancers. The charts below reflect survival rates for specific types of cancers treated at Children's Mercy as well as frequency of diagnosis.